Frontiers The agony and the efficacy: central mechanisms of GLP 1 induced adverse events and their mitigation by GIP Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial The Lancet GLP 1s: The Second Serving Citrini Research Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial The Lancet Efficacy and safety of cagrilintide 2.4 mg in adults with overweight obesity: Data from REDEFINE 1 Understanding Cagrilintide: Benefits and Uses